Company / Shareholders' Equity
Benitec Biopharma Inc. Shareholders' Equity History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$10.2M
FY2021
5-year range
$10.2M / $16.6M
FY2020-FY2021
Trend
-38.3%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$10M in FY2021.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, shareholders' equity decreased 38.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $10.2M | -38.3% |
| FY2020 | $16.6M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026